n-hydroxysuccinimide s-acetylthioacetate and Carcinoma

n-hydroxysuccinimide s-acetylthioacetate has been researched along with Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belliot, SO; Crommelin, DJ; Haisma, HJ; Smit, RH; Storm, G; Vingerhoeds, MH	1

Other Studies

1 other study(ies) available for n-hydroxysuccinimide s-acetylthioacetate and Carcinoma

Article	Year
Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity. Pharmaceutical research, 1996, Volume: 13, Issue:4 Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Binding Sites; Carcinoma; Cross-Linking Reagents; Daunorubicin; Drug Carriers; Female; Glucuronates; Glucuronidase; Humans; Imidoesters; Immunoglobulin Fab Fragments; Liposomes; Mice; Ovarian Neoplasms; Prodrugs; Succinimides; Sulfides; Tumor Cells, Cultured	1996

Article

Year

Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity.

Pharmaceutical research, 1996, Volume: 13, Issue:4

Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Binding Sites; Carcinoma; Cross-Linking Reagents; Daunorubicin; Drug Carriers; Female; Glucuronates; Glucuronidase; Humans; Imidoesters; Immunoglobulin Fab Fragments; Liposomes; Mice; Ovarian Neoplasms; Prodrugs; Succinimides; Sulfides; Tumor Cells, Cultured

1996